Background. The role of serum tumor markers in non‐small cell lung cancer (NSCLC)
remains undefined. New proposed markers have seldom been rigorously compared with …

Background Biomarkers play a role in identifying, managing, and predicting cancer
outcomes. In lung cancer, they are used at various time points. Doubts remain regarding …

Abstract The human epididymis 4 (HE4) protein is expressed in the epididymis and
respiratory tract. We previously reported that HE4 is also expressed in pulmonary …

Objective To discuss the serum value of human epididymis protein 4 (HE4) in the diagnosis
of lung can-cer and to analyse the serum levels of HE4 in different pathological types and …

Objective To evaluate the diagnostic value of the serum tumor markers carcinoembryonic
antigen (CEA), cytokeratin-19-fragment (CYFRA21-1), squamous cell carcinoma associated …

Background: Lung cancer is the most common cause of malignant pleural effusion (MPE).
Serum human epididymis secretory protein 4 (HE4) is a useful diagnostic marker for lung …

Background: Lung cancer is the leading cause of cancer death in most countries. Although
early diagnosis and treatment critically influence prognosis, lung cancers are generally only …

BACKGROUND: Serum biomarkers are not in routine clinical use for diagnosis, prognosis,
or treatment selection in lung cancer. OBJECTIVE: We examined serum protein biomarkers …

Background: Lung cancer (LC) is the leading cause of deaths caused by cancer worldwide.
A diagnostic test for LC is needed for monitoring high-risk populations. Patients and …

Fundamental studies on biomarkers as well as developed assays for their detection can
provide valuable information facilitating clinical decisions. For patients with lung cancer …